da Silva Jorge Santos
Chief Executive Officer, Director · MoonLake Immunotherapeutics
- 2025
- Jul 13, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies da Silva Jorge Santos files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Kristian Reich - $8.14M in MLTX purchases and sales in the last 12 months
- Matthias Bodenstedt - $3.20M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is da Silva Jorge Santos?
da Silva Jorge Santos is a corporate insider, tracked as Chief Executive Officer, Director of MoonLake Immunotherapeutics (MLTX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did da Silva Jorge Santos last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 6 filings going back to 2025.
Has da Silva Jorge Santos been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($8.73M) across all tracked filings.
